Application 211420
- Type
- ANDA
- Sponsor
- AKORN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXCARBAZEPINE | OXCARBAZEPINE | SUSPENSION;ORAL | 300MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211420-001 | OXCARBAZEPINE | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | 782e0a99824c… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | AB | 2021-07-09 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211420-001 | OXCARBAZEPINE | 300MG/5ML | SUSPENSION / ORAL | 2021-07-09 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211420-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A211420-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A211420-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A211420-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A211420-001 | AB | 1 | 782e0a99824c… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A211420-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A211420-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A211420-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A211420-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A211420-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A211420-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A211420-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A211420-001 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXCARBAZEPINE | OXCARBAZEPINE | Golden State Medical Supply, Inc. | b9db5c45-8b51-449b-b4af-1a235c08f189 | 2025-12-11 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Glenmark Pharmaceuticals Inc., USA | 1c713b59-a628-42e6-b166-ae71c3913284 | 2025-12-03 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Ajanta Pharma USA Inc. | d947e9b1-2a15-4048-bb4e-fe56b6851848 | 2025-11-30 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Bionpharma Inc. | ec033897-21b4-4d08-83de-042783e89251 | 2025-11-28 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | a1b6a698-f7d9-4adb-9e38-b63e7a85e2b3 | 2025-10-24 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | 1176d5f5-3447-4925-aed8-1a1cb4b5989d | 2025-10-13 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Amneal Pharmaceuticals LLC | 2515391e-3a88-4226-92e5-f641c8409fe5 | 2025-10-01 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Coupler LLC | 3f15c889-4386-850b-e063-6294a90a8dbf | 2025-09-18 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Preferred Pharmaceuticals Inc. | e156339c-f79e-4a20-b9da-f50bea948213 | 2025-09-05 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| oxcarbazepine | OXCARBAZEPINE | Macleods Pharmaceuticals Limited | 962098cc-2d84-4723-a296-b110f1fd659e | 2025-08-29 | Warnings, Adverse reactions | oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Ascend Laboratories, LLC | 3f36f519-c30c-4929-afa0-9844dc531e3f | 2025-07-22 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Marlex Pharmaceuticals, Inc | d3684d55-0564-4849-bdf6-b91f22a3e28c | 2025-06-25 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Ingenus Pharmaceuticals, LLC | 70798ca9-0eda-49c0-8a7c-b775b6ae3d69 | 2025-04-12 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Proficient Rx LP | 433d9d03-a36e-42c6-8e4d-f333ed60e45a | 2025-03-01 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | NorthStar RxLLC | 1746d95f-c529-45ba-a520-0c135e8edda8 | 2025-02-03 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | DirectRx | dbea45c2-e166-b557-e053-2995a90a7643 | 2025-01-22 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Bryant Ranch Prepack | 23137a89-cbd0-4a5f-8220-f26b7ba54330 | 2025-01-21 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | AvPAK | fd8da0e9-d69b-7587-e053-6294a90a33c0 | 2025-01-09 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | EPIC PHARMA, LLC | 62ab716b-f05f-454d-95b3-1a382cdf7226 | 2025-01-07 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Novadoz Pharmaceuticals LLC | 03bec567-a9c3-4d82-9679-fec5324d0df6 | 2024-11-18 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.